Variable | mGPS 0 (n = 119) | mGPS 1 (n = 11) | mGPS 2 (n = 20) | P-value |
---|---|---|---|---|
Age (years) | 72 (43–91) | 74 (64–82) | 72 (51–79) | 0.14 |
Sex (male/female) | 80/39 | 10/1 | 16/4 | 0.16 |
HBsAg positive (%) | 12 (10) | 2 (18) | 5 (25) | 0.15 |
HCVAb positive (%) | 76 (64) | 1 (9) | 7 (35) | 0 |
AST (IU/l) | 53 (14–240) | 56 (17–238) | 113 (13–384) | <0.0001 |
ALT (IU/l) | 39 (10–202) | 53 (14–190) | 78 (8–157) | 0.02 |
Total serum bilirubin (mg/dl) | 0.8 (0.3-3.1) | 0.7 (0.3-6.1) | 1.6 (0.3-8.3) | 0 |
Albumin (g/dl) | 3.7 (2.1-5) | 3.9 (3.5-4.6) | 3.2 (2.2-3.4) | <0.0001 |
CRP (mg/dl) | 0.1 (0.1-0.9) | 1.5 (1.1-2.9) | 2.6 (1.1-18.8) | <0.0001 |
WBC (cells/mm3 ) | 5200 (1800–14900) | 5900 (3500–10600) | 5800 (3900–12400) | 0.07 |
Platelet count (104/mm3 ) | 13.2 (2.8-30.9) | 25.3 (1.8-42.1) | 17.3 (8.7-44.3) | 0 |
Prothrombin time (%) | 83 (38–100) | 95 (74–100) | 77 (45–97) | 0.01 |
α-fetoprotein (ng/ml) | 22 (1.9-59597) | 77 (2–138011) | 144 (1.7-280600) | 0.05 |
Child-Pugh grade (A/B/C) | 91/26/2 | 10/1/0 | 6/10/4 | <0.0001 |
CLIP score (0/1/2/3≧) | 41/43/24/11 | 3/0/3/5 | 0/7/1/12 | <0.0001 |
JIS score (0/1/2/3≧) | 18/43/41/17 | 0/4/3/4 | 0/1/6/13 | <0.0001 |
BCLC score (0/A/B/C,D) | 18/61/31/9 | 0/4/2/5 | 0/6/2/12 | <0.0001 |
Tumor stage (І,ІІ,ІІІ,ІV) | 21/52/41/5 | 0/4/3/4 | 1/4/4/11 | <0.0001 |
Maximal tumor diameter (mm) | 30 (7–200) | 110 (40–150) | 50 (10–130) | <0.0001 |
Tumor number (solitary/multiple) | 66/53 | 6/5 | 5/15 | 0.04 |
Vascular invasion (absent/present) | 114/5 | 8/3 | 13/7 | <0.0001 |
Extrahepatic metastasis (absent/present) | 117/2 | 10/1 | 17/3 | 0.01 |